IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Delisted

IMUC was delisted on the 16th of October, 2018.

Back to rankings

27 hedge funds and large institutions have $405K invested in ImmunoCellular Therapeutics, Ltd. in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$27.9K
2
+$13K
3
+$7K
4
UBS Group
UBS Group
Switzerland
+$5.38K
5
NFG
Next Financial Group
Texas
+$1K

Top Sellers

1
-$14.3K
2
-$11.2K
3
-$250
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$254K
2
$60K
3
$18K
4
$15K
5
$15K
6
$13K
7
$12K
8
$8K
9
$7K
10
$2K
11
$1K
12
$14
13
$1